Literature DB >> 28961604

Indirect Costs and Family Burden of Pediatric Crohn's Disease in the United States.

Stacy A Kahn1, Chia-Wei Lin, Burak Ozbay, Anthony Wang, Jingdong Chao, Martha Skup.   

Abstract

BACKGROUND: Crohn's disease (CD) negatively impacts patient quality of life and results in greater healthcare utilization. For pediatric CD patients, the burden also extends to their caregivers. We aimed to estimate work loss and productivity costs among caregivers of pediatric CD patients.
METHODS: Data were from Truven MarketScan databases (2000-2012). Patients were <18 years old with ≥2 ICD-9 CD diagnostic codes. Controls were those without CD or ulcerative colitis and were matched to patients by age, Charlson Comorbidity Index, index year, and insurance plan category. Continuous enrollment was required ≥6 months before and ≥12 months after index, defined as the patient's first CD diagnosis date. Outcomes included hours of work loss and associated productivity costs of caregivers 1-year postindex. Work loss and productivity costs were compared between caregivers of patients and controls. Adjustments for unbalanced baseline factors were made using a generalized linear regression model.
RESULTS: Each cohort included 200 study participants and their caregivers. Unadjusted annual hours of work loss after first diagnosis were 214.4 ± 171.5 and 169.6 ± 157.5 for caregivers of CD patients and controls, respectively (P = 0.007). Annual productivity costs were 27.2% ($1122) higher for caregivers of CD patients than controls, estimated at $5243 and $4,121, respectively (P = 0.004). Adjusted cost analyses yielded similar findings. Over the course of a patient's childhood, accumulated productivity losses were $24,118 for CD patients and $18,957 for control caregivers.
CONCLUSIONS: Caregivers of pediatric CD patients have significantly higher loss in productivity costs compared with controls.

Entities:  

Mesh:

Year:  2017        PMID: 28961604     DOI: 10.1097/MIB.0000000000001268

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  4 in total

1.  Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015.

Authors:  Anava A Wren; Rachel Bensen; Lindsay Sceats; Melody Dehghan; Helen Yu; Jessie J Wong; Donna MacIsaac; Zachary M Sellers; Cindy Kin; K T Park
Journal:  Inflamm Bowel Dis       Date:  2018-09-15       Impact factor: 7.290

2.  The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.

Authors:  M Ellen Kuenzig; Lawrence Lee; Wael El-Matary; Adam V Weizman; Eric I Benchimol; Gilaad G Kaplan; Geoffrey C Nguyen; Charles N Bernstein; Alain Bitton; Kate Lee; Jane Cooke-Lauder; Sanjay K Murthy
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

3.  Valuation of Lost Productivity in Caregivers: A Validation Study.

Authors:  Aaron Gelfand; Julie Sou; Rick Sawatzky; Katrina Prescott; Alison Pearce; Aslam H Anis; Christine Lee; Wei Zhang
Journal:  Front Psychol       Date:  2021-08-27

4.  Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Measures to Changes in Disease Status and Quality of Life Among Children and Adolescents With Crohn's Disease.

Authors:  Erica J Brenner; Millie D Long; Courtney M Mann; Wenli Chen; Camila Reyes; Li Lin; Bryce B Reeve; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2021-02-16       Impact factor: 5.325

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.